Reproducibility of spectral-domain optical coherence tomography retinal thickness measurements and conversion to equivalent time-domain metrics in diabetic macular edema

JAMA Ophthalmology

Volumn 132, Issue 9, 2014, Pages 1113-1122

  Bressler, Susan B ^a   Edwards, Allison R ^b   Chalam, Kakarla V ^c   Bressler, Neil M ^a   Glassman, Adam R ^b   Jaffe, Glenn J ^d   Melia, Michele ^b   Saggau, David D ^e   Plous, Oren Z ^f  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JAEB CENTER FOR HEALTH RESEARCH   (United States)

^c UNIVERSITY OF FLORIDA HEALTH SCIENCE CENTER   (United States)

^d DUKE UNIVERSITY EYE CENTER   (United States)

^e Wolfe Eye Clinic   (United States)

^f Gulf Coast Retina Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; HUMAN; INSTITUTIONAL CARE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OPTICAL COHERENCE TOMOGRAPHY DEVICE; REPRODUCIBILITY; RETINAL THICKNESS; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; ALGORITHM; CLINICAL TRIAL; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DEVICES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; MACULAR EDEMA; MALE; MULTICENTER STUDY; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; RETINA;

ADULT; ALGORITHMS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HUMANS; MACULAR EDEMA; MALE; REPRODUCIBILITY OF RESULTS; RETINA; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84907565166     PISSN: 21686165     EISSN: 21686173     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2014.1698     Document Type: Article

References (13)

1. Diabetic Retinopathy Clinical Research Network. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology. 2010;117(6):1064-1077.e35. doi:10.1016/j.ophtha.2010.02.031.
2. Diabetic Retinopathy Clinical Research Network; Googe J, Brucker AJ, Bressler NM, et al. Randomized trial evaluating short-term effects of intravitreal ranibizumab or triamcinolone acetonide on macular edema after focal/grid laser for diabetic macular edema in eyes also receiving panretinal photocoagulation. Retina. 2011;31(6):1009-1027.
3. Chalam KV, Bressler SB, Edwards AR, et al; Diabetic Retinopathy Clinical Research Network. Retinal thickness in people with diabetes and minimal or no diabetic retinopathy: Heidelberg Spectralis optical coherence tomography. Invest Ophthalmol Vis Sci. 2012;53(13):8154-8161.
4. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999;8(2):135-160.
5. Diabetic Retinopathy Clinical Research Network; Krzystolik MG, Strauber SF, Aiello LP, et al. Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema. Ophthalmology. 2007;114(8):1520-1525.
6. Forooghian F, Cukras C, Meyerle CB, Chew EY, Wong WT. Evaluation of time domain and spectral domain optical coherence tomography in the measurement of diabetic macular edema. Invest Ophthalmol Vis Sci. 2008;49(10):4290-4296.
7. Comyn O, Heng LZ, Ikeji F, et al. Repeatability of Spectralis OCT measurements of macular thickness and volume in diabetic macular edema. Invest Ophthalmol Vis Sci. 2012;53(12):7754-7759.
8. Domalpally A, Gangaputra S, Peng Q, Danis RP. Repeatability of retinal thickness measurements between spectral-domain and time-domain optical coherence tomography images in macular disease. Ophthalmic Surg Lasers Imaging. 2010;41(suppl):S34-S41.
9. Leung CK, Cheung CY, Weinreb RN, et al. Comparison of macular thickness measurements between time domain and spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2008;49(11):4893-4897.
10. Sohn EH, Chen JJ, Lee K, Niemeijer M, Sonka M, Abràmoff MD. Reproducibility of diabetic macular edema estimates from SD-OCT is affected by the choice of image analysis algorithm. Invest Ophthalmol Vis Sci. 2013;54(6):4184-4188.
11. Abedi G, Patal P, Doros G, Subramanian ML. Transitioning from Stratus OCT to Cirrus OCT: a comparison and a proposed equation to convert central subfield macular thickness measurements in healthy subjects. Graefes Arch Clin Exp Ophthalmol. 2011;249(9):1353-1357.
12. Krebs I, Hagen S, Smretschnig E, Womastek I, Brannath W, Binder S. Conversion of Stratus optical coherence tomography (OCT) retinal thickness to Cirrus OCT values in age-related macular degeneration. Br J Ophthalmol. 2011;95(11):1552-1554.
13. Ibrahim MA, Sepah YJ, Symons RC, et al. Spectral- and time-domain optical coherence tomography measurements of macular thickness in normal eyes and in eyes with diabetic macular edema. Eye (Lond). 2012;26(3):454-462.